Androgen and Reproductive Disorders

Latest News

Anti-Müllerian Hormone a Potential Biomarker for Menstrual Disturbance in PCOS

By

Morgan E. Meissner

Findings show that anti-Müllerian hormone (AMH) is a strong predictor for menstrual disturbance due to PCOS and that the risk for menstrual disturbance was increased with the degree of elevation of AMH.

Prostate Cancer Risk Higher in Men Receiving Fertility Treatment

Men fathering children through assisted reproduction techniques rather than natural conception have an increased risk for prostate cancer, including early-onset disease.

Providing Contraception Prescriptions Online May Be a Viable Option

Telecontraception — the provision of contraception through a website or smartphone app — is feasible and seems safe for patients.

Hysterectomy Linked to Long-Term Risk for Depression, Anxiety

Hysterectomy, even with ovarian conservation, is associated with an increased long-term risk for de novo depression.

Suboptimal Screening for Hypogonadism in Men Receiving Opioids

More men with long-term opioid use are screened for low testosterone than men taking opioids for a short period of time; however, given the known link between opioid use and low testosterone, these rates were still lower than expected.

Effects of Estrogen-Only Treatment in Women With Prior Hysterectomy

By

Amit Akirov, MD

For women aged 50 to 59 years with a history of bilateral oophorectomy, estrogen therapy may have beneficial effects in the long-term.

Global Position Statement Clarifies Benefits of Testosterone Therapy for Women

Testosterone can be used for postmenopausal women with hypoactive sexual desire dysfunction (HSDD) but is not recommended for other symptoms or medical conditions.

Type and Timing of Menopausal Hormone Therapy May Affect Breast Cancer Risk

By

Amit Akirov, MD

Use of menopausal hormonal therapy for 5 years around the start of menopause may be associated with increased risk for breast cancer.

Bremelanotide Now Available to Treat Hypoactive Sexual Desire Disorder

By

Brian Park, PharmD

Vyleesi (bremelanotide injection; AMAG Pharmaceuticals) is now commercially available through specialty pharmacies, Avella and BioPlus.

History of Concussion Symptoms Linked to Low Testosterone Levels

There is an association between the number of concussion symptoms at the time of injury and the odds of reporting indicators of low testosterone level and erectile dysfunction among former football players.

Do Serum Sex Hormone-Binding Globulin, Testosterone Levels Affect CVD Risk in Men?

By

Tyler Rice

Men with elevated serum sex hormone-binding globulin or lower total testosterone levels might be at greater risk for cardiovascular disease.